Fight Aging!

Fight Aging!

Publication
0 followers

Personal longevity science blog tracking advances in anti-aging biotechnology, rejuvenation research, and advocacy for life-extension therapies

Metabolic Acidosis May Be an Important Contributing Cause of Age-Related Frailty
NewsApr 22, 2026

Metabolic Acidosis May Be an Important Contributing Cause of Age-Related Frailty

A new open‑access study highlights metabolic acidosis—specifically low serum bicarbonate—as a potentially overlooked driver of age‑related frailty. Epidemiologic data link bicarbonate levels below 25 mEq/L to slower gait, reduced muscle strength, and higher mortality, even in seniors with normal kidney function....

By Fight Aging!
Age-Related Degeneration of the Pineal Gland
NewsApr 22, 2026

Age-Related Degeneration of the Pineal Gland

A recent study examined how the human pineal gland’s structure changes with age, identifying two distinct aging pathways: an increase in astrocytes that may compensate for pinealocyte function, and a disruption of lobular architecture that leads to astrocytic atrophy and...

By Fight Aging!
Connecting Gompertz Law Parameters with Specific Outcomes in the Treatment of Aging
NewsApr 22, 2026

Connecting Gompertz Law Parameters with Specific Outcomes in the Treatment of Aging

Researchers used large‑scale Caenorhabditis elegans experiments to re‑interpret the two parameters of the Gompertz mortality equation. They found that reductions in the β parameter correspond to an expanded period of late‑life frailty, while declines in α reflect genuine health‑span extension...

By Fight Aging!
Is Human Life Expectancy Increasing Because Aging Is Progressing More Slowly?
NewsApr 21, 2026

Is Human Life Expectancy Increasing Because Aging Is Progressing More Slowly?

A new open‑access study examines whether rising life expectancy reflects a slower biological aging process or merely a postponement of its onset. Using cohort mortality data from 12 high‑income countries, the authors decompose the Gompertz slope—a proxy for the rate...

By Fight Aging!
The Gut Microbe in INDY Related Longevity in Flies
NewsApr 21, 2026

The Gut Microbe in INDY Related Longevity in Flies

Researchers investigated how the longevity‑associated Indy gene influences the gut microbiome in Drosophila. Indy heterozygous flies displayed lower bacterial load and greater microbial diversity as they aged, while still achieving lifespan extension even in germ‑free conditions. The study linked Indy...

By Fight Aging!
PEPITEM as a Potential Therapy for Autoimmune Arthritis
NewsApr 21, 2026

PEPITEM as a Potential Therapy for Autoimmune Arthritis

Researchers at the University of Birmingham have identified a decline in the anti‑inflammatory peptide PEPITEM as a key driver of worsening inflammatory arthritis with age. Laboratory tests showed that adding synthetic PEPITEM restores white‑blood‑cell responsiveness to adiponectin in early‑stage rheumatoid...

By Fight Aging!
Considering How to Define Animal Models of Intrinsic Capacity in Aging
NewsApr 20, 2026

Considering How to Define Animal Models of Intrinsic Capacity in Aging

A decade after the WHO introduced the intrinsic capacity (IC) framework, researchers still lack a unified way to measure its five domains—cognition, locomotion, vitality, sensory function, and psychological health. Numerous human‑centric metrics exist, but they are not comparable across studies....

By Fight Aging!
ATF5 as a Point of Tradeoff in Muscle Mass versus Muscle Quality
NewsApr 20, 2026

ATF5 as a Point of Tradeoff in Muscle Mass versus Muscle Quality

Researchers discovered that deleting the transcription factor ATF5 in mice prevents the typical age‑related loss of skeletal muscle mass, but this comes at the cost of reduced muscle quality and endurance. ATF5‑deficient mice showed lower activation of mitochondrial quality‑control proteins,...

By Fight Aging!
Mitrix Bio as an Example of the Trend Towards Alternative Paths to Initial Human Data
NewsApr 20, 2026

Mitrix Bio as an Example of the Trend Towards Alternative Paths to Initial Human Data

Mitrix Bio reported preliminary Phase 1 safety results for large‑dose mitochondrial infusions, showing no immediate adverse effects in two older participants. The company simultaneously opened Right‑to‑Try clinics in Dallas, Newport Beach and Palm Beach, offering the experimental therapy under a patient‑driven model. Its...

By Fight Aging!
The Interventions Testing Program Shows that Another Eleven Compounds Do Not Slow Aging in Mice
NewsApr 17, 2026

The Interventions Testing Program Shows that Another Eleven Compounds Do Not Slow Aging in Mice

The National Institute on Aging’s Interventions Testing Program evaluated eleven small‑molecule and supplement candidates—including astaxanthin, meclizine, mitoglitazone, pioglitazone, α‑ketoglutarate, mifepristone, methotrexate, and an atorvastatin‑telmisartan combo—in genetically heterogeneous UM‑HET3 mice and found none extended lifespan. Earlier studies that suggested modest benefits...

By Fight Aging!
Oxygen Sensing as a Component of Differences in Regenerative Capacity Between Species
NewsApr 17, 2026

Oxygen Sensing as a Component of Differences in Regenerative Capacity Between Species

Researchers investigated how oxygen sensing influences tissue regeneration by comparing amphibian and mammalian models. They cultured frog tadpole limbs and mouse embryos under varied oxygen levels, focusing on the HIF1A protein that stabilizes under low oxygen. Reduced oxygen accelerated wound...

By Fight Aging!
In Search of Novel Means to Provoke Mild Mitochondrial Stress to Slow Aging
NewsApr 16, 2026

In Search of Novel Means to Provoke Mild Mitochondrial Stress to Slow Aging

Researchers screened 770 FDA‑approved drugs to find compounds that safely trigger a mild mitochondrial stress response, a process known as mitohormesis that can improve cellular resilience. The screen highlighted terbinafine and miglustat, which extended lifespan and healthspan in C. elegans...

By Fight Aging!
IGF-1 Signaling Suppression Fails to Slow Aging in Mitochondrial Mutator Mice
NewsApr 16, 2026

IGF-1 Signaling Suppression Fails to Slow Aging in Mitochondrial Mutator Mice

Researchers examined whether suppressing insulin-like growth factor‑1 (IGF‑1) signaling could extend the lifespan of mitochondrial mutator mice, which carry a high rate of mitochondrial DNA mutations. Contrary to expectations, reduced IGF‑1 signaling did not increase longevity; most downstream pro‑longevity pathways...

By Fight Aging!
Applying Mendelian Randomization to the Correlation Between Fitness and Health
NewsApr 16, 2026

Applying Mendelian Randomization to the Correlation Between Fitness and Health

Researchers applied a phenome‑wide Mendelian randomization approach to test whether genetically predicted aerobic fitness causally influences health. Screening 712 European‑ancestry phenotypes, they identified 108 discovery associations, with 34 confirming in independent validation. Higher genetically determined fitness correlated with lower risks...

By Fight Aging!
Does Tau Aggregation Spread From Region to Region in the Aging Brain?
NewsApr 15, 2026

Does Tau Aggregation Spread From Region to Region in the Aging Brain?

A new open‑access study examined tau seed activity in postmortem brain tissue from 128 individuals, combining synaptosome assays, genetic data, and fMRI‑derived connectivity. The researchers found that tau seeds originating in early‑affected regions, such as the entorhinal cortex, can induce...

By Fight Aging!
Cellular Senescence and Mitochondrial Dysfunction and the Aging of the Vascular Endothelium
NewsApr 15, 2026

Cellular Senescence and Mitochondrial Dysfunction and the Aging of the Vascular Endothelium

The review links cellular senescence and mitochondrial dysfunction to the aging of the vascular endothelium, showing how reduced nitric‑oxide, oxidative stress, and chronic inflammation drive atherosclerosis, hypertension, and blood‑brain barrier leakage. It details a feedback loop where mitochondrial bioenergetic decline...

By Fight Aging!
Homoharringtonine as a Senotherapeutic Drug
NewsApr 15, 2026

Homoharringtonine as a Senotherapeutic Drug

Researchers used a large‑scale drug‑repositioning screen to identify homoharringtonine (HHT), an FDA‑approved anti‑leukemic agent, as a potent senotherapeutic. In vitro, HHT selectively eliminated senescent pre‑adipocytes while sparing healthy cells. In male mice, HHT cleared senescent adipocytes, restored white‑adipose tissue function,...

By Fight Aging!
Reversing Some Age-Related Changes via Creation of DNA Gaps with the Box A Domain of HMGB1
NewsApr 14, 2026

Reversing Some Age-Related Changes via Creation of DNA Gaps with the Box A Domain of HMGB1

Researchers delivered a plasmid encoding the Box A domain of HMGB1 to perimenopausal cynomolgus macaques, inducing DNA gap formation. The intervention reversed age‑related alterations in the plasma proteome, bringing key markers such as APOE and SHBG back to levels observed...

By Fight Aging!
The Senescence Associated Secretory Phenotype as a Basis for an Aging Clock
NewsApr 14, 2026

The Senescence Associated Secretory Phenotype as a Basis for an Aging Clock

Researchers have created a composite Senescence‑Associated Secretory Phenotype (SASP) Score using large‑scale proteomics and a guided autoencoder transformer model. The score, built on curated SASP proteins from the UK Biobank Pharma Proteomics Project, independently predicts mortality and major chronic diseases...

By Fight Aging!
Evidence for Retrotransposon Suppression to Reduce Biological Age in Humans
NewsApr 13, 2026

Evidence for Retrotransposon Suppression to Reduce Biological Age in Humans

Researchers evaluated two FDA‑approved nucleoside reverse transcriptase inhibitor (NRTI) regimens in healthy adults to see if they could blunt age‑related epigenetic drift. Over 12 weeks, the emtricitabine/tenofovir‑alafenamide (FTC/TAF) combo lowered multiple DNA‑methylation clocks, including DunedinPACE and PhenoAge, and reduced inflammatory...

By Fight Aging!
An Attempt to Obtain Data on Longevity Effects of Human Psilocybin Use
NewsApr 13, 2026

An Attempt to Obtain Data on Longevity Effects of Human Psilocybin Use

A small observational analysis compared the longevity of documented psilocybin users—referred to as psychedelic personalities—with cancer and aging researchers. The study identified 11 psychedelic users, 12 cancer researchers and 5 aging researchers who died between 2010 and 2025, excluding deaths...

By Fight Aging!
Reviewing What Is Known of Sex Differences in Response to Established Longevity Interventions
NewsApr 13, 2026

Reviewing What Is Known of Sex Differences in Response to Established Longevity Interventions

Recent research highlights that male and female mammals, especially mice, respond differently to interventions that aim to slow aging. While women outlive men in most populations, they also endure more disease, a pattern echoed in laboratory rodents where sex‑specific outcomes...

By Fight Aging!
Influenza Vaccination Reduces Cardiovascular Risk Following Infection
NewsApr 10, 2026

Influenza Vaccination Reduces Cardiovascular Risk Following Infection

A new Danish register‑based self‑controlled case series spanning 2014‑2025 shows that influenza infection triggers a sharp, short‑lived surge in acute myocardial infarction and stroke, especially within the first three days. Prior influenza vaccination cuts the excess cardiovascular risk dramatically, with...

By Fight Aging!
NPPA Gene Therapy to Encourage Greater Regeneration Following Heart Attack
NewsApr 10, 2026

NPPA Gene Therapy to Encourage Greater Regeneration Following Heart Attack

Researchers at Columbia Engineering have engineered an RNA‑lipid nanoparticle that programs skeletal muscle to secrete a pro‑ANP precursor, which the heart‑specific enzyme Corin converts into active atrial natriuretic peptide. This two‑phase gene‑therapy bypasses the need for direct cardiac drug delivery,...

By Fight Aging!
Vulnerability to Infection Resulting From the Aging of the Immune System
NewsApr 10, 2026

Vulnerability to Infection Resulting From the Aging of the Immune System

A new review outlines how aging reshapes the immune system, making older adults far more vulnerable to respiratory viruses such as influenza. The authors detail the twin processes of immunosenescence—declining production of new immune cells—and inflammageing, a chronic, low‑grade inflammatory...

By Fight Aging!
Arg-1 Makes Macrophages More Inflammatory, Impairing Cartilage Regeneration with Age
NewsApr 9, 2026

Arg-1 Makes Macrophages More Inflammatory, Impairing Cartilage Regeneration with Age

The study identifies Arginase‑1 (Arg‑1) as a key regulator of age‑dependent macrophage behavior that hampers cartilage regeneration. Single‑cell RNA sequencing shows older animals have fewer anti‑inflammatory macrophage subsets, with Arg‑1 expression declining with age, leading to heightened inflammation. Overexpressing Arg‑1...

By Fight Aging!
PANoptosis in the Aging of the Heart
NewsApr 9, 2026

PANoptosis in the Aging of the Heart

The review spotlights PANoptosis—a hybrid programmed cell‑death process that fuses pyroptosis, apoptosis and necroptosis—and its emerging relevance to cardiac aging. It details how the PANoptosome complex accelerates cardiomyocyte loss, fibrosis and chronic inflammation, key drivers of age‑related heart decline. Preclinical...

By Fight Aging!
High Dose Influenza Vaccine Correlates with Greater Reduction in Dementia Risk
NewsApr 9, 2026

High Dose Influenza Vaccine Correlates with Greater Reduction in Dementia Risk

A retrospective cohort study of U.S. seniors found that receiving a high‑dose inactivated influenza vaccine (H‑IIV) was associated with a significantly lower risk of Alzheimer’s disease compared with the standard‑dose vaccine (S‑IIV). The analysis used claims data from 2014‑2019, covering...

By Fight Aging!
Data on the Effective Long Term Treatment of Transthyretin Amyloidosis
NewsApr 8, 2026

Data on the Effective Long Term Treatment of Transthyretin Amyloidosis

A new open‑label extension of the ATTRibute‑CM trial provides the first long‑term data on acoramidis, an approved transthyretin stabilizer, showing sustained efficacy through month 54 (4½ years). Continuous treatment cut all‑cause mortality by 45% (HR 0.55) and cardiovascular mortality by 49%...

By Fight Aging!
First Human Data for Rubedo Life Sciences' Senolytic Drug RLS-1496
NewsApr 8, 2026

First Human Data for Rubedo Life Sciences' Senolytic Drug RLS-1496

Rubedo Life Sciences reported preliminary Phase 1 data for RLS‑1496, the first topical GPX4‑modulating senolytic tested in humans. The double‑blind, vehicle‑controlled study in the EU evaluated safety, tolerability and early efficacy in plaque psoriasis, atopic dermatitis and photo‑aged skin. Results showed...

By Fight Aging!
The Road to Producing New Bodies Starts with Multi-Organ Pseudo-Embryos
NewsApr 7, 2026

The Road to Producing New Bodies Starts with Multi-Organ Pseudo-Embryos

Biotech researchers are moving from organoid cultures toward multi‑organ pseudo‑embryos that mimic early human development without brains. Companies such as R3 Bio and Kind Biotechnology are pioneering these brain‑less constructs as a bridge between tissue engineering and full‑body regeneration. The...

By Fight Aging!
BCL-2 and Cellular Senescence in Pulmonary Fibrosis
NewsApr 7, 2026

BCL-2 and Cellular Senescence in Pulmonary Fibrosis

Researchers identified BCL-2 as a key blocker of fibroblast apoptosis in idiopathic pulmonary fibrosis (IPF). Conditional over‑expression of BCL‑2 in PDGFRα‑positive fibroblasts generated senescent, pro‑fibrotic myofibroblasts that persisted in mouse lungs. Spatial transcriptomics confirmed BCL‑2‑positive senescent myofibroblasts in human IPF...

By Fight Aging!
UPAR Targeting to Enable CAR T Cell Therapies to Treat Solid Cancers
NewsApr 7, 2026

UPAR Targeting to Enable CAR T Cell Therapies to Treat Solid Cancers

Researchers at Memorial Sloan Kettering demonstrated that CAR T cells engineered to target the urokinase plasminogen activator receptor (uPAR) can eradicate solid‑tumor cells and metastases in multiple preclinical models. uPAR was found elevated in 12 of 14 examined cancer types,...

By Fight Aging!
Academic Clinical Trials for Rapamycin to Answer Questions on Dosing for Anti-Aging Use
NewsApr 6, 2026

Academic Clinical Trials for Rapamycin to Answer Questions on Dosing for Anti-Aging Use

Researchers at UT Health San Antonio have launched a multi‑phase academic clinical trial to evaluate rapamycin’s biological effects in older adults. The program begins with a younger‑cohort benchmark study, then seeks the optimal dose that restores immune and metabolic markers...

By Fight Aging!
A Review Focused on Exerkines in Extracellular Vesicles Generated by Muscle Tissue
NewsApr 6, 2026

A Review Focused on Exerkines in Extracellular Vesicles Generated by Muscle Tissue

A new review examines how muscle‑derived extracellular vesicles (EVs) act as carriers of exercise‑induced exerkines, linking physical activity to systemic health benefits. It details the molecular cargo—proteins, lipids, and non‑coding RNAs—that modulates muscle stem‑cell activation, combats sarcopenia, and influences distant...

By Fight Aging!
Physical Activity Correlates With a Sizable Difference to Late Life Mortality
NewsApr 6, 2026

Physical Activity Correlates With a Sizable Difference to Late Life Mortality

A 15‑year emulated trial of 11,169 Australian women found that consistently meeting WHO guidelines of at least 150 minutes of moderate‑to‑vigorous activity per week cut all‑cause mortality risk by half, equating to a 5.2‑percentage‑point absolute reduction. The study also observed...

By Fight Aging!
Signal Reprogramming as an Approach to the Challenge of cGAS-STING Overactivation
NewsApr 3, 2026

Signal Reprogramming as an Approach to the Challenge of cGAS-STING Overactivation

A new open‑access review highlights the cGAS‑STING pathway as a central driver of ovarian aging, linking DNA and mitochondrial leaks to chronic inflammation and follicle loss. The authors propose three therapeutic angles: small‑molecule inhibitors that silence cGAS or STING, upstream...

By Fight Aging!
Proposing Atrial Fibrillation and Heart Failure to Be Manifestations of the Same Condition
NewsApr 3, 2026

Proposing Atrial Fibrillation and Heart Failure to Be Manifestations of the Same Condition

Researchers propose that atrial fibrillation and heart failure share a common molecular origin: reduced expression of the transcription factor TBX5. Mouse models lacking TBX5 in the atria develop arrhythmias and gene‑expression patterns that closely resemble heart‑failure signatures. Human atrial tissue...

By Fight Aging!
Oral Microbiome Changes in the Correlation Between Periodontal Disease and Cognitive Decline
NewsApr 3, 2026

Oral Microbiome Changes in the Correlation Between Periodontal Disease and Cognitive Decline

Researchers analyzed data from 1,157 participants in the Taizhou Imaging Study, linking periodontal health, salivary microbiome composition, and cognitive function. They found five clinical periodontal indices inversely related to cognition and identified ten bacterial genera, 21 functional pathways, and two...

By Fight Aging!
Oxidized LDL in Vascular Dementia
NewsApr 2, 2026

Oxidized LDL in Vascular Dementia

Oxidized low‑density lipoprotein (oxLDL) is emerging as a key driver of vascular dementia by damaging the brain’s microvascular endothelium and compromising the blood‑brain barrier. Epidemiological data show that each 1 mmol/L increase in LDL raises all‑cause dementia risk by roughly 8%....

By Fight Aging!
NR0B2 Is Protective of Cartilage, But Expression Decreases as Osteoarthritis Progresses
NewsApr 2, 2026

NR0B2 Is Protective of Cartilage, But Expression Decreases as Osteoarthritis Progresses

Researchers identified the orphan nuclear receptor NR0B2 (also known as SHP) as a protective factor in cartilage, with its expression markedly reduced in osteoarthritic tissue. In male mice, global or chondrocyte‑specific deletion of Nr0b2 worsened pain and joint damage after...

By Fight Aging!
Microplastic and Nanoplastic Exposure in the Context of Aging
NewsApr 1, 2026

Microplastic and Nanoplastic Exposure in the Context of Aging

Recent animal research shows that high-dose nanoplastic accumulation can trigger cellular dysfunction, including oxidative stress and senescence. While these harmful exposure levels exceed current environmental concentrations, older adults may experience greater cumulative burden due to lifelong exposure and age‑related physiological...

By Fight Aging!
Remaining Challenges in the Development of Partial Reprogramming Therapies
NewsApr 1, 2026

Remaining Challenges in the Development of Partial Reprogramming Therapies

Partial reprogramming—brief exposure to Yamanaka factors OCT4, SOX2, KLF4 and MYC—has demonstrated modest rejuvenation in mouse studies but carries a substantial cancer risk if cells slip into full pluripotency. Funding is concentrated in a few well‑capitalized firms, notably Altos Labs,...

By Fight Aging!
The Role of Reactive and Senescent Astrocytes in the Aging of the Brain
NewsMar 31, 2026

The Role of Reactive and Senescent Astrocytes in the Aging of the Brain

A new open‑access review examines how aging pushes astrocytes into reactive and senescent states, both of which contribute to neuroinflammation and cognitive decline. The authors synthesize recent single‑cell and transcriptomic studies showing region‑specific astrocyte phenotypes and highlight that reactivity and...

By Fight Aging!
A Gut Microbiome Response to Low Protein Intake Drives Beneficial Browning of Fat Tissue
NewsMar 31, 2026

A Gut Microbiome Response to Low Protein Intake Drives Beneficial Browning of Fat Tissue

Researchers have shown that low‑protein diets (LPDs) stimulate the conversion of white adipose tissue into thermogenic beige fat, mirroring effects seen with cold exposure or β‑adrenergic activation. The browning response depends on specific gut microbes; germ‑free mice fail to brown,...

By Fight Aging!
Efforts to Treat Neurodegenerative Disease by Altering the Gut Microbiome
NewsMar 30, 2026

Efforts to Treat Neurodegenerative Disease by Altering the Gut Microbiome

Research increasingly shows that gut microbiome composition influences brain health, with age‑related dysbiosis linked to Alzheimer’s and Parkinson’s disease. Animal studies demonstrate that probiotic strains such as Lactobacillus and Bifidobacterium can reduce neuroinflammation and improve cognitive markers, while fecal microbiota...

By Fight Aging!
A Novel G9a Inhibitor Reduces Symptoms in Mouse Models of Alzheimer's Disease
NewsMar 30, 2026

A Novel G9a Inhibitor Reduces Symptoms in Mouse Models of Alzheimer's Disease

Researchers have unveiled FLAV-27, a novel G9a histone methyltransferase inhibitor that readily crosses the blood‑brain barrier and exhibits subnanomolar potency. The compound demonstrates high selectivity for G9a over related enzymes and a favorable safety profile, addressing the limitations of earlier...

By Fight Aging!
Reviewing the Aging of Heart Muscle
NewsMar 30, 2026

Reviewing the Aging of Heart Muscle

Researchers review the biological mechanisms behind cardiac aging, highlighting molecular changes such as mitochondrial dysfunction, non‑coding RNA activity, and cellular senescence that impair myocardial energetics and regeneration. The article links these alterations to clinical outcomes like fibrosis, hypertrophy, valve calcification,...

By Fight Aging!
Complicating 7-Ketocholesterol in Aging and Disease
NewsMar 27, 2026

Complicating 7-Ketocholesterol in Aging and Disease

Researchers are intensifying focus on 7‑ketocholesterol (7KC), an oxidized cholesterol derivative known for its cytotoxic, pro‑inflammatory and pro‑apoptotic effects, especially in atherosclerotic lesions and hypercholesterolemia. A new biotech, Cyclarity Therapeutics, has entered early clinical trials aiming to clear 7KC from...

By Fight Aging!